HelixTalk - Rosalind Franklin University's College of Pharmacy Podcast

In this episode, we discuss new evidence for cardiovascular outcomes in diabetics based on the LEADER trial (liraglutide) and CANVAS trials (canagliflozin). We also discuss the new FDA warning for canagliflozin regarding amputation risk.

Direct download: 067_-_DM2017_Part2.mp3
Category:general -- posted at: 6:00am EST